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Abstract 
Multiple sclerosis is a neurological disorder in which the myelin sheaths of axons are damaged 
by the immune response. We report here a three-dimensional structural analysis of brain and 
spinal cord tissues of a mouse model of multiple sclerosis, known as experimental autoimmune 
encephalomyelitis (EAE). EAE-induced mice were raised with or without administration of 
fingolimod, which is used in the treatment of multiple sclerosis. Brains and spinal cords 
dissected from the EAE mice were lyophilized so as to reconstitute the intrinsic contrast of 
tissue elements, such as axons, in X-ray images. Three-dimensional structures of the brain 
hemispheres and spinal cords of the EAE mice were visualized with synchrotron radiation 
microtomography. Microtomographic cross sections reconstructed from the X-ray images 
revealed dilation of capillary vessels and vacuolation in the spinal cord of the EAE mice. 
Vacuolation was also observed in the cerebellum, suggesting that the neuroinflammatory 
response progressed in the brain. The vessel networks and vacuolation lesions in the spinal 
cords were modelled by automatically tracing the three-dimensional image in order to analyze 
the tissue structures quantitatively. The results of the analysis indicated that the distribution of 
vacuolations was not uniform but three-dimensionally localized. The mean vessel diameter 
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showed a linear correlation with the clinical score, indicating that vasodilation is relevant to 
paralysis severity in the disease model. We suggest that vasodilation and vacuolation are related 
with neurological symptoms of multiple sclerosis.   
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1. Introduction 
Multiple sclerosis (MS) is a neurological disorder in which myelinated axons of the central 
nervous system are damaged by the immune response (Compston & Coles, 2008). It has been 
suggested that axonal loss in brain and spinal cord tissue (Suzuki et al., 1969; Bitsch et al., 
2000; DeLuca et al., 2006) correlates with irreversible neurological impairment (Bjartmar et al., 
2003). It has also been shown that axonal damage is associated with inflammation in brain 
tissue (Frischer et al., 2009). The disease process is considered to be initiated by autoreactive 
lymphocytes that cause inflammatory responses in the central nervous system (Dendrou et al., 
2015).  
Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS 
(Constantinescu et al., 2011; Robinson et al., 2014). A number of elements of the 
neuroinflammatory responses observed in MS have been identified in EAE-induced animal 
models (Gold et al., 2006; Steinman and Zamvil, 2006; Farooqi et al., 2010). Although EAE is a 
reductive model (Dendrou et al., 2015) in which the autoimmune response is artificially induced 
using adjuvants, EAE has widely been used for studying pathogenesis of MS as well as potential 
therapeutic interventions (Robinson et al., 2014). Since EAE is characterized by 
neuroinflammation (Brown & Sawchenko, 2007), EAE-induced animal models have been used 
for analyzing the efficacy of immunomodulatory treatments including fingolimod (Fujino et al., 
2003), natalizumab (Yednock et al., 1992), and glatiramer (Teitelbaum et al., 1971).  
Fingolimod is a sphingosine 1-phosphate receptor agonist (Brinkmann et al., 2002) and 
shows immunosuppressive activity in animal models of graft rejection and autoimmune diseases 
(Chiba et al., 1998; Matsuura et al., 2000). It has been reported that administration of 
fingolimod starting from the day of EAE induction suppressed the development of an 
autoimmune response (Brinkmann et al., 2002; Fujino et al., 2003). The administration of 
fingolimod after EAE onset improved the clinical score of neurological symptoms (Webb et al., 
2004). The effectiveness of fingolimod is ascribable to the inhibition of T-cell infiltration into 
the central nervous system (Kataoka et al., 2005). It has been also shown that fingolimod 
promotes the restoration of blood brain barrier via its effects on microvascular cells (Balatoni et 
al., 2007; Foster et al., 2009).  
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We have reported a three-dimensional analysis of a mouse brain hemisphere using 
synchrotron radiation microtomography (Mizutani, Saiga, Ohtsuka et al., 2016). Axonal 
networks in the brain hemisphere were reconstructed from three-dimensional images of 
lyophilized tissues. Since water is the primary component of soft tissue, its removal by 
lyophilization can recover the intrinsic X-ray contrast of myelin and enable visualization of the 
brain-wide network of axonal tracts in the mouse brain hemisphere. In this study, we used the 
same method to create a three-dimensional visualization of brain hemispheres and spinal cords 
of EAE-induced mice, which were raised with or without administration of fingolimod after the 
onset of the neurological symptoms. Microtomographic sections of spinal cords of the EAE 
mice showed dilation of capillary vessels and micrometer-scale vacuolation. Vacuolation was 
also observed in cerebellums of the EAE mice. Although a microtomographic study of the EAE 
mouse (Cedola et al., 2017) revealed thinning of the capillary wall, the relationship between the 
tissue structure and neurological symptoms have not been delineated. In order to analyze 
structural alterations in the spinal cord tissue, three-dimensional Cartesian coordinate models of 
vessel networks and vacuolation lesions were built by tracing the three-dimensional image 
according to the method used in the structural analysis of human brain neurons (Mizutani et al., 
2018). The relationship between the tissue structure and clinical score was then quantitatively 
analyzed on the basis of the obtained Cartesian coordinate models.  
 
2. Materials and Methods 
2.1 EAE mouse 
All mice were kept in the SPF animal facility at Tokai University School of Medicine and 
fed ad libitum under a 12:12 light and dark cycle. C57BL/6J mice nine weeks of age were 
purchased from CLEA Japan. The animal experiment of this study was approved by the 
Institutional Animal Care and Use Committee at Tokai University (approval number 161073) 
and performed in accordance with the institutional guidelines.  
After acclimating the mice for eight days in the animal facility, EAE was induced using a 
Hooke Kit (Hooke Laboratories, MA, USA), as reported previously (Mendel et al., 1995). First, 
ten mice were immunized subcutaneously with an emulsion of MOG35-55 in complete Freund's 
adjuvant, and followed by intraperitoneal administration of pertussis toxin dissolved in 
phosphate-buffered saline. Since one of the mice showed a leakage of the injected emulsion, it 
was excluded from the experiment. The first injection day was referred to as day 0. On day 1, 
pertussis toxin was administrated again intraperitoneally. Five control mice received injections 
of saline.  
Mice were weighed daily and clinically scored on a scale of 0–5: 0 = no symptoms, 1 = limp 
tail, 2 = weakness of hind limbs, 3 = complete paralysis of hind limbs, 4 = complete paralysis of 
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hind limbs and partial paralysis of forelimbs, and 5 = death or euthanized. In-between scores 
were recorded if the symptoms were between these definitions. Wet chow and hydrogel were 
placed on the cage base when the mice appeared to have difficulty feeding. The immunized 
mice showed paralysis symptoms from day 9 and reached an overall mean score of 2.9 on day 
18. On that day, the immunized mice were divided into two groups in a balanced manner in 
accordance with their clinical scores. From the grouping day, one group consisting of five mice 
(F1–F5) received daily administration of fingolimod (Wako Chemical, Japan) saline at 1 
mg/kg/day perorally. The other EAE group consisting of four mice (E1–E4) and the control 
group consisting of five mice (C1–C5) received saline. Mouse E1 of the non-treated group 
developed severe paralysis and was euthanized on day 25 with a subcutaneous injection of 
pentobarbital. The other mice were euthanized on day 28.  
 
2.2 Preparation of brain and spinal cord samples 
The brains of the EAE and control mice were dissected immediately after euthanasia under a 
perfusion fixation using formaldehyde saline. The right hemispheres of the dissected brains 
were embedded in paraffin to prepare Klüver-Barrera sections under the standard procedure. 
The left hemispheres were used in the X-ray microtomographic analysis. Vertebral segments of 
Th10–L3 corresponding to spinal cord segments of Th13–Co1 were dissected and immersed in 
formaldehyde saline. Then, the spinal cords were excised from the vertebra. The anterior and 
posterior ends of the excised spinal cords approximately corresponding to Th13 and S3–S4 
segments were used for preparing Klüver-Barrera sections. The spinal cords of remaining 
segments were used in the X-ray microtomographic analysis.  
The brain and spinal cord samples for the microtomographic analysis were dehydrated in an 
ethanol series and further soaked in t-butyl alcohol, as reported previously (Mizutani, Saiga, 
Ohtsuka et al., 2016). The samples were frozen at -20ºC overnight and then lyophilized for 1 
hour using a JFD-310 freeze drying device (JEOL, Japan). The lyophilized tissue samples were 
attached to mounting rods by using epoxy glue.  
 
2.3 Microtomography 
Synchrotron radiation microtomography was performed at the BL20B2 beamline (Goto et 
al., 2001) of SPring-8. The samples were mounted on the rotation stage by using brass fittings. 
Transmission images were recorded with a CMOS-based X-ray imaging detector (AA40P and 
ORCA-Flash4.0, Hamamatsu Photonics, Japan) using a P43 scintillator screen. The field of 
view and effective pixel size of the detector were 5.63 mm × 5.63 mm and 2.75 µm × 2.75 µm, 
respectively. Transmission images of the spinal cord samples were acquired with a rotation step 
of 0.1° and exposure time of 500 ms using 8-keV monochromatic X-rays. The X-ray energy was 
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calibrated with nickel foil. Since the sample length was longer than the viewing field height, 
multiple datasets were collected by shifting the sample along its longitudinal axis. Datasets of 
the brain hemisphere samples were collected with the offset CT setup, in which the sample 
rotation axis was placed at the right end of the viewing field and transmission images were 
acquired by rotating the sample through 360° and using 12-keV monochromatic X-rays. The 
rotation step per frame was 0.05°, and the exposure time per frame was 200 ms. The X-ray 
energy was calibrated with gold foil. 
The obtained datasets were subjected to tomographic reconstruction using the RecView 
software available from https://mizutanilab.github.io/ under the BSD 2-Clause License. 
Microtomographic sections of multiple datasets were aligned and stacked in order to reconstruct 
a three-dimensional image of the entire sample. The spatial resolutions of the microtomographic 
sections were estimated to be 6–8 μm by using three-dimensional square-wave patterns 
(Mizutani et al., 2008) and Fourier domain plot (Mizutani, Saiga, Takekoshi et al., 2016). The 
mean X-ray linear attenuation coefficient (LAC) of the whole brain hemisphere was calculated 
from the volume showing LACs larger than 0.5 cm-1. The mean X-ray LAC of the cerebellum 
was calculated by defining the cerebellum region with a polygon lasso.  
 
2.4 Structural analysis 
Since the microtomographic sections of the EAE and control mice showed differences in 
vacuolation and in the capillary vessel networks of the spinal cords, we built Cartesian 
coordinate models of the vacuolation lesions and vessel networks by using the method reported 
for geometric analysis of human brain neurons (Mizutani et al., 2018). The role of the data 
manager was allotted to RS, while the role of the data analyst was allotted to RM in order to 
eliminate human biases from the model building. The data manager reconstructed 
three-dimensional images from the microtomographic datasets and coded dataset names, but did 
not have access to the analysis results. The data analyst built Cartesian coordinate models of 
tissue structures from the three-dimensional images, but did not have access to the sample name. 
After the analyst finished building models for all of the samples, the Cartesian coordinate files 
were locked down. The manager then disclosed the sample name to the analyst so that the tissue 
structures between the animal groups could be compared.  
The models were built in five steps: 1) generation of the initial model of capillary vessel 
network, 2) manual editing of the working model, 3) model refinement with the conjugate 
gradient minimization, 4) automatic vacuole scanning, and 5) final examination. Steps 1) – 3) 
were performed as reported previously (Mizutani et al., 2018). In the generation of the initial 
model, the entire three-dimensional image was divided into image sections of 1.4 mm thickness, 
and each image section was scanned by calculating the gradient vector flow to find luminal 
6 
structures. The luminal structures found in the scan were traced using a three-dimensional Sobel 
filter to build capillary vessel models. An attenuation coefficient threshold of -1.5 cm-1 was used 
in the tracing process. The computer-generated model was examined manually and edited to 
connect adjacent vessel structures, to remove models built into non-luminal structures, and to 
add vessel models that were not traced in the automatic model generation. The edited model was 
refined through conjugate gradient minimization of a target function that represents the fitness 
of the model to the image (Mizutani et al., 2018). Next, vacuolation spheres or ellipsoids with 
intensities lower than 0.5 cm-1 and diameters of 20–40 μm were searched. The vessel models 
were used for masking the vacuolation search so as to avoid building vacuolar models in the 
vessel structure. Finally, the working model was examined manually to remove structures built 
outside the spinal cord.  
A high-resolution MRI study of the vertebra of a C57BL/6J mouse has been reported 
(Harrison et al., 2013). A sagittal section of the vertebra indicated that the length of spinal cord 
segments of L1-L5 was 7.2–7.3 mm and the dorso-ventral thickness of the L1 segment was 
1.5–1.6 mm. In the microtomographic section of the lyophilized spinal cord, the mean 
dorso-ventral thickness of the L1 segment was 0.996 mm, indicating that 64% shrinkage 
occurred in the sample preparation process. This estimation suggests that the length of L1–L5 
segments in the lyophilized spinal cord is approximately 4.6 mm. Therefore, we analyzed 
structures within 4.6 mm from the L1 end. The geometry of the vessel structures was analyzed 
using the method for geometric analysis of human brain neurons (Mizutani et al., 2018). The 
mean diameter of the capillary vessels was calculated by averaging the diameters of the nodes 
of the vessel models.  
Coordinate errors of protein crystal structures have been estimated from Luzzati plots 
(Luzzati, 1952) or sigma-A plots (Read, 1986). The coordinate errors of most crystal structures 
have been reported to be approximately 1/10th of their spatial resolution. In this study, we built 
and refined Cartesian coordinate models of tissue structures according to the methods of protein 
crystallography (Kleywegt & Jones, 1997). Although a method for evaluating the coordinate 
errors of tissue structures has not been established, we suggest that those of the obtained models 
were 0.6–0.8 μm, because the resolutions of the obtained images were 6–8 μm and the models 
were built according to the methods used in protein crystallography.  
 
2.5 Statistical tests 
Statistical tests of the clinical score and structural parameters were performed using the R 
software. Significance was defined as p < 0.05. Two-sided Welch's t-tests were used to examine 
the equality of the clinical score and structural parameters between animal groups. Pearson's 
correlation coefficients were calculated for analyzing correlations between the structural 
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parameters and the clinical score.  
 
3. Results 
3.1 EAE induction 
The clinical scores of each mouse are summarized in Table 1. The EAE-induced mice 
showed symptoms of neurological disorder, such as paralysis of limbs and disability of postural 
maintenance. The control mice showed no neurological symptoms. The mean clinical score of 
the final three days of the fingolimod-treated EAE mice (1.9 for 5 mice) was lower than that of 
the non-treated mice (3.0 for 4 mice), although the difference was insignificant (Welch's t-test, p 
= 0.23).  
 
Table 1. Clinical score and structural parameters of EAE-induced and control mice 
Group Mouse 
ID  
Mean clinical 
score 
X-ray attenuation 
coefficient (cm-1) 
Spinal cord structure 
From 
onset  
Final 
3 d 
Whole 
brain 
Cere- 
bellum 
Number of 
vacuoles 
Number 
of vessel 
nodes 
Vessel 
diameter 
(μm) 
EAE / 
non-treated 
E1 2.9 4.2 1.47 1.64 1221 30886 9.5
E2 2.8 3.5 1.49 1.67 2241 26846 9.4
E3 2.3 3.0 1.50 1.67 2917 32299 9.7
E4 1.5 1.2 1.49 1.61 664 35776 8.8
EAE / 
fingolimod 
F1 2.7 2.5 1.51 1.68 3631 24839 9.2
F2 0.8 1.2 1.49 1.65 729 27753 8.7
F3 2.2 2.2 1.48 1.62 2043 25940 8.8
F4 2.9 3.0 1.42 1.58 2092 23247 9.1
F5 1.0 0.8 1.52 1.68 742 34947 8.4
Control C1 0.0 0.0 1.41 1.62 336 4902 8.5
C2 0.0 0.0 1.52 1.65 392 27654 8.3
C3 0.0 0.0 1.48 1.64 282 19268 8.4
C4 0.0 0.0 1.45 1.65 357 37952 7.7
C5 0.0 0.0 1.46 1.67 293 19396 7.8
 
 
3.2 Microtomography and histology of brain hemisphere and spinal cord 
Figure 1 shows microtomographic cross sections of the L1 spinal cord segments of 
EAE-induced and control mice. Histologies of adjacent tissue sections are also shown. The 
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major differences between the cross sections of the EAE and control mice are the dilation of 
capillary vessels and micrometer-scale vacuolation showing low X-ray attenuation coefficients. 
A microtomographic section of the spinal cord of a non-treated EAE mouse with severe 
paralytic symptoms (Figure 1a) showed vacuolated and damaged tissue structures mainly in the 
ventral white matter of the spinal cord. The vacuolation lesions were also discernible in the 
Klüver-Barrera section (Figure 1b). Myelin vacuolation or vesiculation is the common 
pathologic alteration of the myelin sheath in demyelinating diseases (Duncan & Radcliff, 2016). 
Microtomographic and histological sections of a control mouse (Figure 1e and 1f) showed a 
homogeneous and dense structure without vacuolation. A fingolimod-treated EAE mouse with 
moderate paralytic symptoms (mouse F5) showed fewer vacuolation lesions (Figure 1c and 1d) 
compared with a non-treated EAE mouse with severe symptoms (mouse E2; Figure 1a and 1b). 
The clinical score of this fingolimod-treated F5 mouse (total mean of 1.0 and final 3-day mean 
of 0.8; Table 1) suggested that the autoimmune response and resultant structural degeneration in 
the spinal cord tissue were moderate.  
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a        b 
  
c        d 
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Figure 1. Microtomographic cross sections of L1 spinal cord segments and Klüver-Barrera 
sections of adjacent tissues. Linear attenuation coefficients from -0.5 cm-1 to 3.5 cm-1 were 
rendered with gray scale. Paraffin sections 5 μm in thickness were prepared for Klüver-Barrera 
staining. Scale bars: 250 μm. Insets in the upper right show three-fold magnification of areas 
indicated with boxes. (a) Microtomographic section of non-treated EAE mouse E2. (b) A 
Klüver-Barrera section of non-treated EAE mouse E2. (c) Microtomographic section of 
fingolimod-treated EAE mouse F5. (d) Klüver-Barrera section of fingolimod-treated EAE 
mouse F5. (e) Microtomographic section of control mouse C1. (f) Klüver-Barrera section of 
control mouse C5.   
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Figure 2 shows a three-dimensional rendering of the brain hemisphere and cross sections of 
the cerebrum and cerebellum. Micrometer-scale vacuolation was observed in the cerebellar 
white matter of the non-treated EAE mouse (Figure 2d). This indicates that the tissue 
degeneration observed in the spinal cord also progressed in the cerebellum. In contrast, 
cerebrum sections showed no apparent structural differences between the EAE mice and the 
controls (Figure 2b and 2c) and shared similar structures of axonal tracts. This suggested that 
the inflammatory response had not reached the cerebrum during the mouse raising period. X-ray 
attenuation coefficients of the whole brain hemisphere and the cerebellum are summarized in 
Table 1. The mean attenuation coefficients of the cerebellum were higher than those of the 
whole hemisphere, although no significant differences were found between the EAE and the 
control mice (Welch's t-test, p = 0.34 for the whole hemisphere). It has been reported that lipid 
localization in axonal tracts can be visualized as a contrast of the X-ray attenuation coefficient 
(Mizutani, Saiga, Ohtsuka et al., 2016). These results indicated that the total lipid content was 
retained in the brain tissue even after EAE induction.  
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b     c 
   
Figure 2. Structures of brain hemispheres of a non-treated EAE mouse and a control mouse. 
Scale bars: 500 μm. (a) Three-dimensional rendering of the left brain hemisphere of control 
mouse C5. Linear attenuation coefficients from 0.5 cm-1 to 3.5 cm-1 were rendered with gray 
scale. Approximate section positions are indicated with lines. (b) Coronal section of the 
cerebrum of non-treated EAE mouse E3. Linear attenuation coefficients from -0.5 cm-1 to 3.5 
cm-1 were rendered with gray scale. (c) Coronal section of the cerebrum of control mouse C5.  
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Figure 2 (cont'd). Structures of brain hemispheres of a non-treated EAE mouse and a control 
mouse. Scale bars: 500 μm. (d) Coronal section of the cerebellum of EAE mouse E3. (e) 
Coronal section of the cerebellum of control mouse C5. Insets on the lower right are three-fold 
magnifications of the cerebellar white matter indicated with boxes. Micrometer-scale vacuoles 
showing low X-ray attenuation coefficients were observed in the white matter.  
 
3.3 Analysis of three-dimensional tissue structures 
Since the microtomographic sections of the EAE mice showed structural alterations such as 
the vacuolation and the capillary dilation in the spinal cord tissue, we built Cartesian coordinate 
models of vessel networks and vacuolation lesions. The three-dimensional image of the spinal 
cord (Figure 3a) was used for building models of vessel network and vacuolation. The model 
building was performed according to the method used for analyzing neuronal structures of 
human cerebral tissues (Mizutani et al., 2018). The initial model of vessel network (Figure 3b) 
was generated using a three-dimensional Sobel filter and the gradient vector flow. The 
computer-generated model was superposed with the three-dimensional image and manually 
edited. The edited model was refined with conjugate gradient minimization (Figure 3c). The 
obtained vessel model was then subjected to vacuole scanning, in which vacuolation lesions 
with diameters of 20–40 μm were automatically built (Figure 3d). Since vessels and vacuoles 
were built by placing and connecting nodes in the three-dimensional coordinate space (Figure 
3e), the geometry of the three-dimensional tissue structure could be analyzed quantitatively 
from the model coordinates.  
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Figure 3. (a) Dorsal view of spinal cord of a non-treated EAE mouse (mouse E1). Linear 
attenuation coefficients from -3.5 cm-1 (black) to 0.0 cm-1 (white) were rendered with an inverse 
gray scale to visualize the internal vessel network. Scale bar: 250 μm. (b) The initial model was 
generated by automatically tracing luminal structures in the three-dimensional image. Structures 
are color-coded. (c) The computer-generated model was examined and edited manually to build 
the vessel network model. (d) Vacuolation lesions indicated with dots were identified by 
scanning the three-dimensional image. (e) Stereo drawing of a vessel model (blue) superposed 
on its three-dimensional map of linear attenuation coefficients (purple). The coefficient map 
was contoured at -1.0 cm-1 with a grid size of 2.75 μm. 
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Figure 4 shows Cartesian coordinate models of vessels and vacuolation lesions in the spinal 
cords. These models illustrate that the EAE mouse had more vacuoles than the control had. 
Statistics of the tissue structures are summarized in Table 1. The number of vacuoles in the EAE 
mice was significantly higher than that of controls (Welch's t-test, p = 0.0029), though the 
amount of vacuolation did not exactly match the severity of the neurological symptoms. The 
major fraction of vacuoles was localized in specific regions of the spinal cord tissue (Supporting 
Information, Movie 1), presumably representing localization of neuroinflammation loci. The 
mean diameter of the capillary vessels was 9.4 μm for the non-treated EAE mice, 8.8 μm for the 
fingolimod-treated EAE mice, or 8.1 μm for the controls. The vessel diameters of the EAE mice 
were significantly higher than those of the controls (Welch's t-test, p = 0.0019). The difference 
in vessel diameter between the non-treated and fingolimod-treated EAE mice was not 
significant (p = 0.066), though the lack of significance is ascribable to the small size of the 
animal groups.  
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Figure 4. Vessel network and vacuolation of (a) non-treated EAE mouse E1, (b) 
fingolimod-treated EAE mouse F2, and (c) control mouse C4. Vessel networks are drawn in red 
and vacuolation lesions in blue. Scale bar: 250 μm. 
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A scatter plot of the vessel diameter versus the mean clinical score of the final three days is 
shown in Figure 5a. The plot illustrates a linear correlation between the vessel diameter and the 
clinical score (Pearson's correlation coefficient r = 0.89, p = 1.6 × 10-5). This indicates that the 
capillary dilation in the spinal cord is relevant to the neurological symptoms of the EAE mice. A 
plot of the number of vacuoles versus the clinical score is shown in Figure 5b. The number of 
vacuoles shows a stronger correlation with the mean score from onset to euthanasia (Pearson's 
correlation coefficient r = 0.83, p = 0.00020) than with the mean score of the final three days 
(Pearson r = 0.75, p = 0.0019). This suggests that vacuolation represents the cumulative effect 
of the inflammatory response. Other geometric parameters, including length, curvature, and 
torsion of the capillary vessel network, showed no remarkable correlation with the clinical 
score.  
 
a     b 
   
Figure 5. (a) Scatter plot of mean vessel diameter versus mean clinical score of the final three 
days before dissection. (b) Scatter plot of number of vacuoles versus mean clinical score from 
onset to euthanasia. Non-treated EAE mice are represented with triangles, fingolimod-treated 
EAE mice with squares, and controls with circles. Lines indicate linear regressions for all mice.  
 
 
4. Discussion 
The microtomographic analysis of the EAE mice indicated that 1) vacuolation lesions were 
generated in the spinal cord and the cerebellar white matter of the EAE mice, and that 2) the 
vessel diameter of the spinal cord showed a linear correlation with the clinical score of paralysis 
symptoms.  
Myelin vacuolation is a common pathologic alteration of the myelin sheath (Duncan & 
Radcliff, 2016) and has been reported to be one of four ultrastructural patterns of myelin 
destruction in MS (Lucchinetti et al., 1996). A rat model of neuromyelitis optica, in which EAE 
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was induced with an anti-aquaporin-4 antibody, indicated that vacuolation was generated in the 
spinal cord tissue (Kurosawa et al., 2015). A rabbit model of spinal cord ischemia showed a 
correlation between the amount of vacuolation and motor function score (Kurita et al., 2006). 
The results of this study revealed that the number of vacuolations was correlated with the mean 
clinical score from the onset of EAE to euthanasia. Therefore, the amount of vacuolation can be 
a measure of the total inflammatory activity over the disease course.  
The linear correlation between the vessel diameter and clinical score indicates that vessel 
dilation is relevant to the neurological symptoms of the EAE mice. The vessel dilation in the 
EAE mice is ascribable to vasodilative mediators associated with inflammation or to congestion 
of the spinal cord tissue. It has been reported that the vessel network of the spinal cord of an 
EAE mouse appeared ramified and dense (Cedola et al., 2017). Some cardiovascular mediators, 
such as sphingosine-1-phosphate, promote lymphocyte egress and hence are likely to be 
responsible for the inflammatory response in the spinal cord tissue (Camm et al., 2014).  
It has been suggested that the pathology of MS is the consequence of impaired venous 
drainage from the central nervous system (D'haeseleer et al., 2011). An MRI study indicated that 
the high inflammatory lesions in MS are associated with increased cerebral blood volume 
(Bester et al., 2015). Arterial transit time of cerebral blood flow was reported to be longer in MS 
patients with greater disability than in controls (Paling et al., 2014). These reports suggest that 
alterations in cerebral blood flow are a marker of MS pathology. It has been reported that nitric 
oxide synthase is expressed at significant levels in the brains of MS patients (Bagasra et al., 
1995; Chuman, 2006). It has been also shown that an inhibitor of nitric oxide synthase can 
reduce the severity of EAE (Zhao et al., 1996). Therefore, vasodilative mediators, such as nitric 
oxide, should contribute to the pathology of MS. This is consistent with the results of this study 
indicating that neurological symptoms correlate with vasodilation.  
The fingolimod used in this study causes persistent vasoconstriction in long-term treatment 
of MS (Camm et al., 2014), suggesting the relevance of the vasculature structure in MS. 
Although disease-modifying therapeutics help to control the symptoms of MS, they do not cure 
the disease or reverse the damage (Loma & Heyman, 2011). As most MS therapeutics have been 
developed so as to suppress the immune-mediated inflammation (Dendrou et al., 2015), other 
mechanisms of action should be explored in order to improve the treatment of MS. We suggest 
that vasodilation control may be an alternative path along which to pursue a cure of MS.  
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Supporting Information legends 
Movie 1. Three-dimensional structure of the vessel network and vacuolation distribution in the 
spinal cord of non-treated EAE mouse E1. Vacuolation lesions are indicated with crosses. 
Structures are color-coded. 
 
 
 
 
